Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Vaccines

Free Subscription Articles published in JAMA Retrieve available abstracts of 98 articles: HTML format

Single Articles

June 2025
1. GOSTIN LO, Reiss D, Offit PA
   Changed Recommendations for COVID-19 Vaccines for Children and Pregnant Women: A Failure of Process, Policy, and Science.
   JAMA. 2025 Jun 13. doi: 10.1001/jama.2025.10658.
   PubMed    
   
   
   
2. ZETTLER PJ, Cha S, Despres S, Lurie P, et al
   FDA Review of Novavax's COVID-19 Vaccine-Regulatory Integrity and Deviations From Standard Practice.
   JAMA. 2025 Jun 9. doi: 10.1001/jama.2025.9898.
   PubMed    
   
   
   
3. PRASAD V, Kaslow DC, Yang S
   Pausing Chikungunya Vaccination and Accelerated Approval.
   JAMA. 2025 Jun 5. doi: 10.1001/jama.2025.9393.
   PubMed    
   
   
   
4. DONG E, Saiyed S, Nearchou A, Okura Y, et al
   Trends in County-Level MMR Vaccination Coverage in Children in the United States.
   JAMA. 2025 Jun 2:e258952. doi: 10.1001/jama.2025.8952.
   PubMed    
   
   
   May 2025
5. ANDERER S
   RSV Vaccine Shows Real-World Effectiveness in Older Adults.
   JAMA. 2025 May 30. doi: 10.1001/jama.2025.7762.
   PubMed    
   
   
   
6. KARABA AH, Segev DL, Werbel WA
   Respiratory Syncytial Virus Vaccination-Reply.
   JAMA. 2025 May 7. doi: 10.1001/jama.2025.2141.
   PubMed    
   
   
   
7. VICENTE-RABANEDA EF, Cardenoso-Domingo L, Castaneda S
   Respiratory Syncytial Virus Vaccination.
   JAMA. 2025 May 7. doi: 10.1001/jama.2025.2137.
   PubMed    
   
   
   
8. RUDMAN SPERGEL AK, Wu I, Deng W, Cardona J, et al
   Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults >/=50 Years: A Randomized Clinical Trial.
   JAMA. 2025 May 7:e255646. doi: 10.1001/jama.2025.5646.
   PubMed     Abstract available
   
   
   
9. ANDERER S
   Shingles Vaccine Linked to Lower Dementia Risk.
   JAMA. 2025 May 2. doi: 10.1001/jama.2025.5644.
   PubMed    
   
   
   April 2025
10. ANDERER S
    Childhood Vaccination Rates Still Lag Behind Prepandemic Levels.
    JAMA. 2025 Apr 25. doi: 10.1001/jama.2025.4675.
    PubMed    
    
    
    
11. KIANG MV, Bubar KM, Maldonado Y, Hotez PJ, et al
    Modeling Reemergence of Vaccine-Eliminated Infectious Diseases Under Declining Vaccination in the US.
    JAMA. 2025 Apr 24. doi: 10.1001/jama.2025.6495.
    PubMed     Abstract available
    
    
    
12. POMIRCHY M, Bommer C, Pradella F, Michalik F, et al
    Herpes Zoster Vaccination and Dementia Occurrence.
    JAMA. 2025 Apr 23:e255013. doi: 10.1001/jama.2025.5013.
    PubMed     Abstract available
    
    
    
13. O'LEARY ST
    Strategies for Communicating With Parents About Vaccines.
    JAMA. 2025 Apr 9. doi: 10.1001/jama.2025.4882.
    PubMed    
    
    
    
14. JACOBS JW, Booth GS
    Unreliable Vaccine Information and the Erosion of Science.
    JAMA. 2025 Apr 9. doi: 10.1001/jama.2025.5723.
    PubMed    
    
    
    
15. EDWARDS KM
    Approaches for MMR Vaccination During a Measles Outbreak and Evolving Domestic Attitudes.
    JAMA. 2025 Apr 9. doi: 10.1001/jama.2025.5679.
    PubMed    
    
    
    March 2025
16. OPEL DJ, O'Leary ST, Stockwell MS
    The Future of Research on Vaccine Uptake at the National Institutes of Health.
    JAMA. 2025 Mar 31. doi: 10.1001/jama.2025.4725.
    PubMed    
    
    
    
17. ANDERER S
    HPV Vaccine Cuts Cervical Precancer Incidence, but Rural Access Gaps Remain.
    JAMA. 2025 Mar 28. doi: 10.1001/jama.2025.2573.
    PubMed    
    
    
    
18. RADER B, Walensky RP, Rogers WS, Brownstein JS, et al
    Revising US MMR Vaccine Recommendations Amid Changing Domestic Risks.
    JAMA. 2025 Mar 14. doi: 10.1001/jama.2025.3867.
    PubMed    
    
    
    
19. SCHWEITZER K
    Amid Texas Measles Outbreak, Clinicians Struggle to Offset Increasing Vaccine Hesitancy.
    JAMA. 2025 Mar 14. doi: 10.1001/jama.2025.2932.
    PubMed    
    
    
    
20. LAURING AS, Edson C, Surie D, Dawood FS, et al
    Genomic Characterization of RSV in the US by Vaccination Status.
    JAMA. 2025 Mar 10. doi: 10.1001/jama.2025.1225.
    PubMed    
    
    
    
21. ANDERER S
    Sudan Virus Disease Outbreak in Uganda Spurs First-Ever Ebola Vaccine Trial.
    JAMA. 2025 Mar 7. doi: 10.1001/jama.2025.1347.
    PubMed    
    
    
    February 2025
22. ANDERER S
    FDA Issues Warning of Guillain-Barre Syndrome Risk for 2 RSV Vaccines.
    JAMA. 2025 Feb 21. doi: 10.1001/jama.2025.0545.
    PubMed    
    
    
    
23. WU PH, Ho YY, Chang CM
    Electronic Nudges for Influenza Vaccination.
    JAMA. 2025 Feb 10. doi: 10.1001/jama.2024.26532.
    PubMed    
    
    
    
24. JOHANSEN ND, Biering-Sorensen T
    Electronic Nudges for Influenza Vaccination-Reply.
    JAMA. 2025 Feb 10. doi: 10.1001/jama.2024.26535.
    PubMed    
    
    
    
25. EDWARDS KM
    Reflections on the Successes of Pediatric Vaccines.
    JAMA. 2025 Feb 6. doi: 10.1001/jama.2025.0865.
    PubMed    
    
    
    January 2025
26. CALIFF RM
    Consequences and Opportunities From Poor Uptake of COVID Vaccinations Despite Strong Evidence.
    JAMA. 2025 Jan 17. doi: 10.1001/jama.2025.0255.
    PubMed    
    
    
    December 2024
27. KARABA AH, Hage C, Sengsouk I, Balasubramanian P, et al
    Antibody Response to Respiratory Syncytial Virus Vaccination in Immunocompromised Persons.
    JAMA. 2024 Dec 30. doi: 10.1001/jama.2024.25395.
    PubMed    
    
    
    
28. ANDERER S
    Global Measles Cases Rose 20% in 1 Year as Vaccine Coverage Fell Short.
    JAMA. 2024 Dec 27. doi: 10.1001/jama.2024.25514.
    PubMed    
    
    
    
29. RUBIN R
    In Search of COVID-19 Vaccines That Elicit Mucosal Immunity and Stop Transmission.
    JAMA. 2024 Dec 20. doi: 10.1001/jama.2024.23627.
    PubMed    
    
    
    
30. ANDERER S
    Trial Shows It's Safe to Get COVID-19, Flu Vaccines at the Same Time.
    JAMA. 2024 Dec 13. doi: 10.1001/jama.2024.24891.
    PubMed    
    
    
    
31. ANDERER S
    CDC Recommends Lowering the Pneumococcal Vaccine Age to 50.
    JAMA. 2024 Dec 6. doi: 10.1001/jama.2024.24265.
    PubMed    
    
    
    
32. ANDERER S
    CDC Recommends Second COVID-19 Vaccine Dose for Older Adults.
    JAMA. 2024 Dec 6. doi: 10.1001/jama.2024.24258.
    PubMed    
    
    
    
33. MARKS KM, Kang M, Umbleja T, Cox A, et al
    HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse: The BEe-HIVe Randomized Clinical Trial.
    JAMA. 2024 Dec 1:e2424490. doi: 10.1001/jama.2024.24490.
    PubMed     Abstract available
    
    
    
34. HUNG I, Lok AS
    Overcoming Hepatitis B Vaccine Nonresponsiveness.
    JAMA. 2024 Dec 1. doi: 10.1001/jama.2024.24028.
    PubMed    
    
    
    November 2024
35. ANDERER S
    Mpox Vaccine Appears Safe for Use in Adolescents.
    JAMA. 2024 Nov 22. doi: 10.1001/jama.2024.23619.
    PubMed    
    
    
    
36. PAN CQ, Dai E, Mo Z, Zhang H, et al
    Tenofovir and Hepatitis B Virus Transmission During Pregnancy: A Randomized Clinical Trial.
    JAMA. 2024 Nov 14. doi: 10.1001/jama.2024.22952.
    PubMed     Abstract available
    
    
    
37. ANDERER S
    WHO Approves Another HPV Vaccine for Single-Dose Use.
    JAMA. 2024 Nov 8. doi: 10.1001/jama.2024.22565.
    PubMed    
    
    
    October 2024
38. ANDERER S
    Study: MMR Vaccine Protection Wanes Slightly Over Time.
    JAMA. 2024 Oct 25. doi: 10.1001/jama.2024.21822.
    PubMed    
    
    
    
39. ANDERER S
    CDC Recommends Mpox Vaccine for Travelers to Central and Eastern Africa.
    JAMA. 2024 Oct 18. doi: 10.1001/jama.2024.21298.
    PubMed    
    
    
    
40. ANDERER S
    FDA Greenlights Nasal Spray Flu Vaccine for Use at Home.
    JAMA. 2024 Oct 18. doi: 10.1001/jama.2024.21299.
    PubMed    
    
    
    
41. RUBIN R
    Researchers Are Exploring the Role of Shingles-and a Protective Role of Shingles Vaccine-in Dementia.
    JAMA. 2024 Oct 18. doi: 10.1001/jama.2024.0227.
    PubMed    
    
    
    
42. TITANJI BK, Hazra A, Zucker J
    Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies: A Review.
    JAMA. 2024 Oct 14. doi: 10.1001/jama.2024.21091.
    PubMed     Abstract available
    
    
    
43. JOHANSEN ND, Vaduganathan M, Bhatt AS, Modin D, et al
    Electronic Nudges to Increase Influenza Vaccination in Patients With Chronic Diseases: A Randomized Clinical Trial.
    JAMA. 2024 Oct 11. doi: 10.1001/jama.2024.21060.
    PubMed     Abstract available
    
    
    
44. ANDERER S
    Study: Single Dose of Modified Smallpox Vaccine Effective for Mpox.
    JAMA. 2024 Oct 11. doi: 10.1001/jama.2024.20120.
    PubMed    
    
    
    
45. COLLIER AY, McMahan K, Jacob-Dolan C, Liu J, et al
    Decline of Mpox Antibody Responses After Modified Vaccinia Ankara-Bavarian Nordic Vaccination.
    JAMA. 2024 Oct 3. doi: 10.1001/jama.2024.20951.
    PubMed    
    
    
    
46. RIVERS C, Watson C, Phelan AL
    The Resurgence of Mpox in Africa.
    JAMA. 2024;332:1045-1046.
    PubMed    
    
    
    September 2024
47. PARK S, Davis AM, Pillai AA
    Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma.
    JAMA. 2024;332:1013-1014.
    PubMed    
    
    
    
48. SCRUGGS-WODKOWSKI E, Malani P
    What Is Pertussis?
    JAMA. 2024;332:1030.
    PubMed    
    
    
    
49. ANDERER S
    FDA Approves Updated COVID-19 Vaccines.
    JAMA. 2024 Sep 20. doi: 10.1001/jama.2024.19127.
    PubMed    
    
    
    
50. HARRIS E
    As Mpox Cases Surge in Africa, WHO Declares a Global Emergency-Here's What to Know.
    JAMA. 2024;332:862-864.
    PubMed    
    
    
    
51. GOSTIN LO, Singaravelu S, Hynes N
    Smallpox Readiness: Modern Strategies Against an Ancient Disease.
    JAMA. 2024;332:873-874.
    PubMed    
    
    
    
52. ANDERER S
    Combo COVID-19 and Flu mRNA Vaccine Falls Short of Total Flu Protection.
    JAMA. 2024 Sep 13. doi: 10.1001/jama.2024.18194.
    PubMed    
    
    
    
53. ANDERER S
    Malaria Vaccine Candidate Could Prevent Infection During Pregnancy.
    JAMA. 2024 Sep 13. doi: 10.1001/jama.2024.18197.
    PubMed    
    
    
    
54. ANDERER S
    Promising Top-Line Results for RSV Vaccine in Immunocompromised Adults.
    JAMA. 2024 Sep 6. doi: 10.1001/jama.2024.17607.
    PubMed    
    
    
    
55. SURIE D, Self WH, Zhu Y, Yuengling KA, et al
    RSV Vaccine Effectiveness Against Hospitalization Among US Adults 60 Years and Older.
    JAMA. 2024 Sep 4:e2415775. doi: 10.1001/jama.2024.15775.
    PubMed    
    
    
    
56. GOODMAN JL, Bright RA, Lurie N
    H5 Influenza Vaccines-Moving Forward Against Pandemic Threats.
    JAMA. 2024 Sep 4. doi: 10.1001/jama.2024.17488.
    PubMed    
    
    
    August 2024
57. ANDERER S
    WHO Announces Project to Develop an mRNA H5N1 Vaccine for Humans.
    JAMA. 2024 Aug 30. doi: 10.1001/jama.2024.15887.
    PubMed    
    
    
    
58. SEMENZATO L, Le Vu S, Botton J, Bertrand M, et al
    Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies.
    JAMA. 2024 Aug 26:e2416380. doi: 10.1001/jama.2024.16380.
    PubMed     Abstract available
    
    
    
59. ANDERER S
    Current Shingles Vaccine Associated With Lower Risk of Dementia.
    JAMA. 2024 Aug 23. doi: 10.1001/jama.2024.15879.
    PubMed    
    
    
    
60. ANDERER S
    Vaccines Lowered Risk of Long COVID in US Veterans, but Not Completely.
    JAMA. 2024 Aug 16. doi: 10.1001/jama.2024.15518.
    PubMed    
    
    
    
61. HARRIS E
    NIH Starts Testing Nasal COVID-19 Vaccine in US.
    JAMA. 2024 Aug 2. doi: 10.1001/jama.2024.13769.
    PubMed    
    
    
    
62. COFFEY D
    The World Needs a Staph Vaccine-New Research Could Bring It a Step Closer.
    JAMA. 2024 Aug 2. doi: 10.1001/jama.2024.1015.
    PubMed    
    
    
    
63. HARRIS E
    Prenatal RSV Vaccine Not Tied to Higher Risk of Preterm Births.
    JAMA. 2024 Aug 2. doi: 10.1001/jama.2024.13773.
    PubMed    
    
    
    July 2024
64. HARRIS E
    CDC Revises RSV Vaccination Recommendation for Older Adults in US.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13385.
    PubMed    
    
    
    
65. HARRIS E
    COVID-19 Vaccination in Early Pregnancy Not Linked to Birth Defects.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13389.
    PubMed    
    
    
    
66. YOUMSHAJEKIAN L
    COVID-19 May Protect Against the Common Cold-Here's Why Knowing That Could Lead to Better Vaccines.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13382.
    PubMed    
    
    
    
67. AGARWAL SD, Cook BL, Liebman JB
    Effect of Cash Benefits on Health Care Utilization and Health: A Randomized Study.
    JAMA. 2024 Jul 22:e2413004. doi: 10.1001/jama.2024.13004.
    PubMed     Abstract available
    
    
    
68. HARRIS E
    Symptoms After COVID-19 Vaccination Tied to Higher Antibody Levels.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.12231.
    PubMed    
    
    
    
69. RUBIN R
    Picking the Optimal Variant to Target in Updated COVID-19 Vaccines Is Tricky.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.10992.
    PubMed    
    
    
    
70. 
    The Conquest of Yellow Fever.
    JAMA. 2024;332:175.
    PubMed    
    
    
    June 2024
71. HARRIS E
    WHO: As Mpox Outbreaks Continue, Cases May Be Underestimated.
    JAMA. 2024;331:2070.
    PubMed    
    
    
    
72. SCRUGGS-WODKOWSKI EA, Malani PN, Linder KA
    Therapies to Decrease Severe Respiratory Syncytial Virus Illness.
    JAMA. 2024;331:2127-2128.
    PubMed    
    
    
    
73. ZIMBROFF RM, Deardorff WJ, Song S, Nikolov MC, et al
    Use of a Financial Incentive Code for In-Home COVID-19 Vaccination of Homebound Older Adults.
    JAMA. 2024 Jun 20. doi: 10.1001/jama.2024.9673.
    PubMed    
    
    
    
74. DEAN N, Amin AB
    Test-Negative Study Designs for Evaluating Vaccine Effectiveness.
    JAMA. 2024 Jun 12. doi: 10.1001/jama.2024.5633.
    PubMed    
    
    
    May 2024
75. HARRIS E
    Lower Dose of Mpox Vaccine Was Safe, Effective.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8635.
    PubMed    
    
    
    
76. HARRIS E
    Microneedle Vaccine Patches Generated Immune Response in Children.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8629.
    PubMed    
    
    
    
77. QATO DM, Romley JA, Myerson R, Goldman D, et al
    Shingles Vaccination in Medicare Part D After Inflation Reduction Act Elimination of Cost Sharing.
    JAMA. 2024 May 23. doi: 10.1001/jama.2024.7348.
    PubMed    
    
    
    
78. HARRIS E
    CDC Warns of Surge in Meningococcal Disease in US.
    JAMA. 2024;331:1614.
    PubMed    
    
    
    
79. RUBIN R
    Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could Soon Be Available.
    JAMA. 2024 May 17. doi: 10.1001/jama.2024.7370.
    PubMed    
    
    
    
80. HARRIS E
    National Academies Report: COVID-19 Vaccines Don't Cause Many Potential Harms.
    JAMA. 2024 May 10. doi: 10.1001/jama.2024.7724.
    PubMed    
    
    
    
81. HARRIS E
    Five-in-One Meningitis Vaccine Rolls Out.
    JAMA. 2024 May 10. doi: 10.1001/jama.2024.7727.
    PubMed    
    
    
    
82. AGRAWAL S, Ross JS, Ramachandran R
    Implications for Public Health Regulation if Chevron Deference Is Overturned.
    JAMA. 2024;331:1443-1444.
    PubMed    
    
    
    April 2024
83. ALLEN MR, Desai N, Namazi A, Leas E, et al
    Characteristics of X (Formerly Twitter) Community Notes Addressing COVID-19 Vaccine Misinformation.
    JAMA. 2024 Apr 24:e244800. doi: 10.1001/jama.2024.4800.
    PubMed    
    
    
    
84. VOELKER R
    What Is Hepatitis D Infection?
    JAMA. 2024 Apr 18. doi: 10.1001/jama.2024.1317.
    PubMed    
    
    
    
85. ANDERER S
    Could "Empathetic Refutation" Help Clinicians Sway Vaccine Skeptics?
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4493.
    PubMed    
    
    
    
86. HARRIS E
    Measles Outbreaks in US and Abroad Prompt CDC Vaccination Alert.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5153.
    PubMed    
    
    
    
87. HARRIS E
    COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5152.
    PubMed    
    
    
    
88. HARRIS E
    Safety Concerns Put a Stop to Maternal RSV Vaccine Study.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5155.
    PubMed    
    
    
    
89. DAWOOD FS, Payne AB, McMorrow ML
    Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus.
    JAMA. 2024 Apr 11. doi: 10.1001/jama.2024.5859.
    PubMed    
    
    
    March 2024
90. HARRIS E
    COVID-19 Infection Tied to Slight Cognitive Deficits.
    JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2087.
    PubMed    
    
    
    
91. EDWARDS KM, Griffin MR
    Postmarketing Vaccine Safety Assessments: Important Work in Progress.
    JAMA. 2024;331:915-917.
    PubMed    
    
    
    
92. LU Y, Matuska K, Nadimpalli G, Ma Y, et al
    Stroke Risk After COVID-19 Bivalent Vaccination Among US Older Adults.
    JAMA. 2024;331:938-950.
    PubMed     Abstract available
    
    
    
93. HARRIS E
    WHO Issues First Recommendations for Managing Diphtheria.
    JAMA. 2024;331:907.
    PubMed    
    
    
    
94. ANDERER S
    CDC Recommends Additional COVID-19 Booster for Older Adults.
    JAMA. 2024 Mar 13. doi: 10.1001/jama.2024.2071.
    PubMed    
    
    
    
95. HARRIS E
    HPV Vaccination Rates Stagnated During COVID-19 Pandemic.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1569.
    PubMed    
    
    
    February 2024
96. ANDERSSON NW, Thiesson EM, Hviid A
    Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines.
    JAMA. 2024 Feb 26:e241036. doi: 10.1001/jama.2024.1036.
    PubMed    
    
    
    
97. JAMIESON KH, Johnson KB, Cappola AR
    Misinformation and the Vaccine Adverse Event Reporting System.
    JAMA. 2024 Feb 26. doi: 10.1001/jama.2024.1757.
    PubMed    
    
    
    
98. HARRIS E
    New Prevention Guidance for Antibiotic-Resistant Meningococcal Cases.
    JAMA. 2024 Feb 21. doi: 10.1001/jama.2024.0731.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.